All In Biotech

Free tool

FAERS Monitor: Serevent

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020692 or its brand name (Serevent, Salmeterol Xinafoate). Reports on generic versions are filed under their own applications.

Reports

8,614

Serious

5,067

59% of reports

Hospitalization

2,500

Death reported

965

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,269
  • drug ineffective1,232
  • asthma919
  • cough597
  • headache474
  • pneumonia413
  • nausea403
  • wheezing378
  • dizziness368
  • chest discomfort357
  • fatigue355
  • pharmaceutical product complaint318
  • chest pain317
  • malaise303
  • diarrhoea289

Reports by year received

View as table
YearReports
20041,507
2005678
2006562
2007426
2008446
2009446
2010433
2011313
2012283
2013316
2014328
2015331
2016370
2017282
2018292
2019307
2020252
2021245
2022178
2023171
2024231
2025126
202688

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,545 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pharmaceutical product complaintSignal31830.327.18,870
asthmaSignal91920.018.816,532
wheezingSignal37815.714.25,153
chest discomfortSignal3578.57.72,372
dyspnoeaSignal1,2695.55.24,765
coughSignal5975.24.82,048
chest painSignal3174.23.8771
pneumoniaSignal4133.12.8600
drug ineffectiveSignal1,2322.32.2946
headache4741.81.7189
dizziness3681.81.6134
malaise3031.71.586
nausea4031.21.120
fatigue3551.11.04
diarrhoea2891.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.